>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance
: SOHU -6%, CYOU -3.7%, ROP -3.7%, RJET -3.4%, NSC -1.3%

M&A news: MYL -13.6% (TEVA withdraws bid for MYL), NEM -1.2% (divests stake in Valcambi Gold Refinery)

Select China related names showing weakness after Shanghai closed -8.5%: CMCM -10.5%, CNIT -9.1%, WBAI -8.8%, JKS -8.2%, SFUN -7.9%, JMEI -7.7%, YGE -7%, QIHU -6.4%, DL -6.1%, JD -5.6%, RENN -5.3%, DANG -4.8%, KNDI -4.7%, FENG -4.7%, SINA -4.7%, NQ -4.6%, AMCN -4.2%, BITA -4%, CTRP -3.8%, BIDU -3.2%, BABA -2.7%

Other news: BLRX -21.2% (confirms negative top-line results from Bellerophon's (BLPH) PRESERVATION I clinical trial for Bioabsorbable Cardiac Matrix), AMDA -8.1% (modest pullback following Friday's gains), GOLD -3.1% (provides Q2 update), FCAU -2.3% (reaches consensual resolution of NHTSA investigation on 23 recall campaigns), FCX -2.2% (likely in response to Chinese equity mkts)

Analyst comments: MTW -5.7% (downgraded to Sell from Neutral at Goldman ), SFXE -5.4% (downgraded to Hold from Buy at Stifel ), GRUB -4.5% (downgraded to Market Perform from Outperform at Cowen), NAV -3.8% (downgraded to Sell from Neutral at Goldman), RARE -3.2% (downgraded to Equal-Weight from Overweight at Morgan Stanley ), TEX -1.4% (ddowngraded to Sell from Neutral at Goldman), JAH -1.1% (removed from Franchise Pick List at Jefferies
)